Oster Chemical & Pharmaceutical Works Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.91 M
- Company Age 92 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.10 M
About Oster Chemical & Pharmaceutical Works
Oster Chemical & Pharmaceutical Works Pvt Ltd (OCPWPL) was founded in India on 27 April 1932 and has a glorious history of 92 years and ten months.Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.91 M.
The company currently has active open charges totaling ₹1.10 M.
Dipak Dutta, Shantanu Chakravarty, and Keya Dutta serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231WB1932PTC007345
- Company No.
007345
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Apr 1932
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Oster Chemical & Pharmaceutical Works?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dipak Dutta  | Managing Director | 02-Dec-1998 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shantanu Chakravarty | Director | 01-Apr-2011 | Current |
| Keya Dutta | Director | 23-Mar-2010 | Current |
Financial Performance of Oster Chemical & Pharmaceutical Works.
Oster Chemical & Pharmaceutical Works Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Oster Chemical & Pharmaceutical Works?
In 2017, Oster Chemical & Pharmaceutical Works had a promoter holding of 95.30% and a public holding of 4.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.10 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Dec 2010 | State Bank Of India | ₹1.10 M | Open |
How Many Employees Work at Oster Chemical & Pharmaceutical Works?
Oster Chemical & Pharmaceutical Works has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oster Chemical & Pharmaceutical Works, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oster Chemical & Pharmaceutical Works's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
